Growth Metrics

Cardlytics (CDLX) Cash & Current Investments (2016 - 2026)

Cardlytics filings provide 11 years of Cash & Current Investments readings, the most recent being $59.8 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 14.9% to $59.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $59.8 million through Mar 2026, up 14.9% year-over-year, with the annual reading at $48.7 million for FY2025, 25.73% down from the prior year.
  • Cash & Current Investments hit $59.8 million in Q1 2026 for Cardlytics, up from $48.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $208.3 million in Q1 2022 and bottomed at $44.0 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $93.6 million, with a median of $90.1 million recorded in 2023.
  • The largest annual shift saw Cash & Current Investments tumbled 66.05% in 2022 before it increased 14.9% in 2026.
  • Cardlytics' Cash & Current Investments stood at $121.9 million in 2022, then dropped by 24.67% to $91.8 million in 2023, then decreased by 28.57% to $65.6 million in 2024, then dropped by 25.73% to $48.7 million in 2025, then increased by 22.75% to $59.8 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Cash & Current Investments are $59.8 million (Q1 2026), $48.7 million (Q4 2025), and $44.0 million (Q3 2025).